daniel smith is a 44-year-old man who was diagnosed with adhd-inattentive subtype in college, but has not taken medication for the last several years. he is seeking treatment now because of declining work performance following a promotion 7 months ago. specifically, he complains of difficulty finishing papers and staying focused during meetings and fears that his boss is losing confidence in him. assessment confirms a diagnosis of adhd-inattentive subtype. after 2 months treatment on a therapeutic dose of a long-acting stimulant, he states that his focus, sustained attention, and distractibility are much better, but that he still can't get organized and that it takes him longer to complete tasks than it should. would it be appropriate for the pmhnp to raise the dose of the stimulant to address his residual symptoms?